Caliber Healthcare Solutions Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Employee Data

  • Caliber Healthcare Solutions has 115 Employees.(i)
  • Caliber Healthcare Solutions grew their employee count by 47% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A84-1%N/AN/A
#2
N/A45-18%N/AN/A
#3
N/A7958%N/AN/A
#4
N/A18214%N/AN/A
#5
N/A5730%N/AN/A
#6
N/A2839%N/AN/A
#7
N/A4561%N/AN/A
#8
$1.7M35-57%N/AN/A
#9
N/A2630%N/AN/A
#10
$7.5M879%N/AN/A
Add Company

What Is Caliber Healthcare Solutions?

Caliber Healthcare Solutions empowers high-quality physicians and advanced practice providers with greater career flexibility, autonomy, and mobility. As the leading provider-centric staffing firm, we serve as a trusted advisor both to providers and organizations competing for scarce clinical talent. Built on a foundation of specialization and exceptional support, Caliber’s workforce solutions ensure the quality and continuity of patient care in communities across the U.S. We deliver exceptional outcomes by putting the provider at the center of our purpose. Since launching in 2004, Caliber has grown rapidly through the integration of six powerful brands: NEXTLocums, Onyx MD, Vitruvian Medical, Medpath Partners, Randstad Locum Tenens, and Lucidity. Previously, these legacy brands went to market collectively as Health Carousel Locum Tenens. Today, we are Caliber, working with all the precision, speed, and quality that the name implies. We are unified by one shared mission: To empower physicians and advanced practice providers with professionally satisfying and financially rewarding practice opportunities, flexible schedules that fit their lifestyle goals, and the opportunity to provide exceptional patient care.

keywords:N/A

N/A

Total Funding

115

Number of Employees

N/A

Revenue (est)

47%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.8M116N/AN/A
#2
$31.3M11632%N/A
#3
$146.6M116-3%$459.7M
#4
$31.3M1167%N/A
#5
$20.9M1167%N/A